675 related articles for article (PubMed ID: 9509459)
1. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
[TBL] [Abstract][Full Text] [Related]
3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
4. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
[TBL] [Abstract][Full Text] [Related]
5. Impact of renal failure on metabolic bone parameters in a vitamin D-deficient patient cohort.
Reinhardt W; Dolff S; John P; Kribben A; Witzke O
Clin Nephrol; 2011 May; 75(5):403-9. PubMed ID: 21543019
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism.
Schwarz A; Merkel S; Leitolf H; Haller H
Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318
[TBL] [Abstract][Full Text] [Related]
8. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
[TBL] [Abstract][Full Text] [Related]
9. Long-term evolution of the mineral metabolism after renal transplantation: a prospective, single-center cohort study.
Van de Cauter J; Sennesael J; Haentjens P
Transplant Proc; 2011 Nov; 43(9):3470-5. PubMed ID: 22099822
[TBL] [Abstract][Full Text] [Related]
10. Calcium and phosphorus metabolism in stable renal transplant recipients.
Khosroshahi HT; Shoja MM; Azar SA; Tubbs RS; Safa J; Etemadi J; Ardalan MR
Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
[TBL] [Abstract][Full Text] [Related]
11. Bone disease in long-term adult kidney transplant patients with normal renal function.
Montalban C; de Francisco AL; Mariñoso ML; Zubimendi JA; García Unzueta M; Amado JA; Arias M
Kidney Int Suppl; 2003 Jun; (85):S129-32. PubMed ID: 12753284
[TBL] [Abstract][Full Text] [Related]
12. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
13. Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients.
Fiedler R; Deuber HJ; Langer T; Osten B; Mohan S; Jehle PM
Nephron Clin Pract; 2004; 96(1):c3-9. PubMed ID: 14752247
[TBL] [Abstract][Full Text] [Related]
14. Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol.
Lobo PI; Cortez MS; Stevenson W; Pruett TL
Clin Transplant; 1995 Aug; 9(4):277-81. PubMed ID: 7579733
[TBL] [Abstract][Full Text] [Related]
15. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation.
Saha HH; Salmela KT; Ahonen PJ; Pietilä KO; Mörsky PJ; Mustonen JT; Lalla ML; Pasternack AI
Scand J Urol Nephrol; 1994 Mar; 28(1):21-7. PubMed ID: 8009188
[TBL] [Abstract][Full Text] [Related]
16. Disorders of calcium metabolism at various times after renal transplantation.
Babarykin D; Adamsone I; Amerika D; Folkmane I; Rozental R
Ann Transplant; 1999; 4(1):46-53. PubMed ID: 10850601
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
Corey RL; Whitaker MD; Crowell MD; Keddis MT; Aqel B; Balan V; Byrne T; Carey E; Douglas DD; Harrison ME; Vargas HE; Rakela J
Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
19. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
20. Bone histology in patients with nephrotic syndrome and normal renal function.
Mittal SK; Dash SC; Tiwari SC; Agarwal SK; Saxena S; Fishbane S
Kidney Int; 1999 May; 55(5):1912-9. PubMed ID: 10231454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
